Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Strong Buy Rating and Raises Price Target for ConnectOne Bancorp

Elaine Mendonca by Elaine Mendonca
January 29, 2024
in Breaking News
0
Banking Trading online
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

On January 29, 2024, Daniel Tamayo, an esteemed analyst at Raymond James, expressed his unwavering confidence in ConnectOne Bancorp (NASDAQ:CNOB) by maintaining a Strong Buy rating. In a notable development, Tamayo has revised the price target for CNOB from $26 to $28, signaling his optimism for the company’s future growth.

Tamayo, a seasoned Wall Street analyst, has consistently demonstrated his expertise in the field. While boasting a success rate of 37.5%, he has proven to be a reliable source of investment advice. Although his average return stands at -1.59%, his latest assessment of ConnectOne Bancorp as a Strong Buy showcases his positive outlook on the stock.

As we delve into the intricacies of Tamayo’s analysis, it becomes evident that he sees great potential in ConnectOne Bancorp. His endorsement of the company’s stock suggests a belief in its ability to thrive in the market. With this revised price target, Tamayo anticipates a promising future for ConnectOne Bancorp, underlining the potential for further value appreciation.

Strong Performance of CNOB Stock on January 29, 2024: Trading Near 52-Week High and Above 200-Day Moving Average

On January 29, 2024, CNOB stock demonstrated a strong performance, trading near the top of its 52-week range and above its 200-day simple moving average. The price of CNOB shares increased by $0.43 since the market last closed, representing a rise of 1.85%. CNOB opened at $23.46 on January 29, 2024, which was $0.22 higher than its previous close. Trading near the top of its 52-week range is a positive sign for CNOB stock. Additionally, trading above its 200-day simple moving average is another positive indicator for CNOB stock. Overall, the performance of CNOB stock on January 29, 2024, was strong, with the stock trading near the top of its 52-week range and above its 200-day simple moving average.

CNOB Stock Performance on January 29, 2024: Revenue Growth but Declining Net Income Raises Concerns

CNOB Stock Performance on January 29, 2024:

Total revenue for CNOB stood at $504.07 million over the past year, representing a significant increase of 30.25% compared to the previous year. However, when compared to the last quarter, the total revenue remained flat at $133.17 million.

CNOB’s net income witnessed a decline both on a yearly and quarterly basis. The net income for the past year was reported at $87.00 million, reflecting a decrease of 30.36% compared to the previous year. In the last quarter, the net income dropped further to $19.27 million, representing a decline of 9.7% since the previous quarter.

CNOB’s EPS for the past year was reported at $2.07, showing a decline of 31.27% compared to the previous year. In the last quarter, the EPS decreased further to $0.46, representing a decline of 9.95% since the previous quarter.

While CNOB’s total revenue has shown impressive growth over the past year, the decline in net income and EPS raises concerns about the company’s ability to maintain profitability. Investors may be cautious about the recent decline in earnings, which could impact the stock’s performance on January 29, 2024.

Investors and analysts will closely monitor CNOB’s future financial reports to determine whether the recent decline in net income and EPS is a temporary setback or a sign of deeper issues. It will be interesting to see how the stock performs in the coming months and whether the company can regain its profitability and investor confidence.

Tags: CNOB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Fiscal (3)

Stock Market Updates ZIM SOFI and ONMD Experience Surges

MA stock news

Analysis of HighYielding Dividend Stocks in the Financial Sector

Biotechnology Market Capitalization

LiveOne Unveils Groundbreaking Addition Splitmind Radio

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com